A Multicenter Phase III Study to Evaluate the Efficacy and Safety of Hepabulin, a New Hepatitis B Immunoglobulin, in Liver Transplantation Recipients with Hepatitis B

Ho Joong Choi; Dong Goo Kim; Soon Il Kim; Hee Jung Wang; Jae Won Joh; Kyung Suk Suh; Seong Hoon Kim

doi:10.12659/AOT.905898

12 December 2017 : Original article

A Multicenter Phase III Study to Evaluate the Efficacy and Safety of Hepabulin, a New Hepatitis B Immunoglobulin, in Liver Transplantation Recipients with Hepatitis B

Ho Joong Choi^{ABCDEF 1}, Dong Goo Kim^{ABDFG 1*}, Soon Il Kim^{BF 2}, Hee Jung Wang^{BF 3}, Jae Won Joh^{BF 4}, Kyung Suk Suh^{BF 5}, Seong Hoon Kim^{BF 6}

DOI: 10.12659/AOT.905898

Ann Transplant 2017; 22:740-748

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Back to the Article

A Multicenter Phase III Study to Evaluate the Efficacy and Safety of Hepabulin, a New Hepatitis B Immunoglobulin, in Liver Transplantation Recipients with Hepatitis B

Your Privacy